Gilead Sciences GILD
NASDAQ GILD
$146.12 +2.68 (+1.87%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Change in Taxes (2009 - 2026)

Gilead Sciences' (GILD) quarterly Change in Taxes came in at -$29.0 million in Q1 2026, up 94.75% YoY from -$14.9 million in Q1 2025, and up 78.36% on a QoQ basis from -$134.0 million in Q4 2025.

Gilead Sciences (GILD) Change in Taxes (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has 18 years of Change in Taxes data on file, last reported at -$29.0 million in Q1 2026.

  • Quarterly Change in Taxes rose 94.75% year-over-year to -$29.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 billion (down 47.3% YoY) and the FY2025 annual result came in at -$2.1 billion, down 187.98% from the prior year.
  • Change in Taxes grew to -$29.0 million in Q1 2026, from -$134.0 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $536.0 million in Q4 2024 to a low of -$1.3 billion in Q2 2025.
  • A 5-year average of -$294.2 million and a median of -$134.0 million in 2025 frame the typical range for Change in Taxes.
  • The widest YoY moves for Change in Taxes: up 176.79% in 2024, down 4082.14% in 2024.
  • Tracing GILD's Change in Taxes over 5 years: stood at $119.0 million in 2022, then slumped by 686.55% to -$698.0 million in 2023, then soared by 176.79% to $536.0 million in 2024, then tumbled by 125.0% to -$134.0 million in 2025, then jumped by 78.36% to -$29.0 million in 2026.
  • The last three Change in Taxes figures came in at -$29.0 million (Q1 2026), -$134.0 million (Q4 2025), and -$122.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -2.22 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -131.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 171.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 171.00 Mn
Jun 30, 2026 171.00 Mn
Mar 31, 2026 -29.00 Mn
Mar 31, 2026 -29.00 Mn
Dec 31, 2025 -134.00 Mn
Dec 31, 2025 -134.00 Mn
Sep 30, 2025 -122.00 Mn
Sep 30, 2025 -122.00 Mn
Jun 30, 2025 -1.30 Bn
Jun 30, 2025 -1.30 Bn
Mar 31, 2025 -552.00 Mn
Mar 31, 2025 -552.00 Mn
Dec 31, 2024 536.00 Mn
Dec 31, 2024 536.00 Mn
Sep 30, 2024 111.00 Mn
Sep 30, 2024 111.00 Mn
Jun 30, 2024 -1.17 Bn
Jun 30, 2024 -1.17 Bn
Mar 31, 2024 -208.00 Mn
Mar 31, 2024 -208.00 Mn